Skip to main content

Fiscal Wizard · Single-issue tearsheet

ATRC / Jun 21, 2026 Run #7409

ATRC

AtriCure, Inc.

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Composite verdict

F 26.0 / 100
Bearish setup · Reversal 9 drivers · 4 gates blocking
  • Accumulation/Distribution Line
  • Multi Top/Bottom
  • Engulfing
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 22nd of 57 in Medical Instruments & Supplies

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 19 signals100% Bear
Momentum Bearish 38Mean-reversion Bearish 19

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -71%
Asset value $9.71Earnings power value $0.45Price $28.80

Priced above its no-growth earnings power value ($0.45/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

50.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Margin of Safety 0
Asset Turnover 77
Forward P/E 0
Capex to Sales 75
Inventory Turnover 0

Technicals Bearish

1.9 / 100

Bearish setup leads (Accumulation/Distribution Line, Multi Top/Bottom, Engulfing); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 8
Engulfing 15
Multi Top/Bottom 16

Risk Gates

4 blocking 5 caution

4 guards active, 21 signals gated.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for ATRC.